Greenlight Capital NEUBASE THERAPEUTICS INC ownership

NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 38 filers reported holding NEUBASE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Greenlight Capital ownership history of NEUBASE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$5,127
-33.1%
2,727,0270.0%0.33%
-25.6%
Q4 2021$7,663
-22.2%
2,727,0270.0%0.44%
-33.6%
Q3 2021$9,844
-24.6%
2,727,0270.0%0.66%
-19.5%
Q2 2021$13,062
-12.8%
2,727,027
+34.5%
0.82%
-21.4%
Q1 2021$14,980
+5.7%
2,027,0270.0%1.04%
+22.4%
Q4 2020$14,169
-7.9%
2,027,0270.0%0.85%
-32.2%
Q3 2020$15,386
-7.9%
2,027,027
+6.5%
1.26%
-30.7%
Q2 2020$16,711
+52.6%
1,903,227
+23.7%
1.81%
+16.1%
Q1 2020$10,954
-1.1%
1,538,4620.0%1.56%
+89.9%
Q4 2019$11,077
+44.3%
1,538,4620.0%0.82%
+48.9%
Q3 2019$7,6771,538,4620.55%